Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
- Figures corrected afterwards (2021).
Gross margin
€ 1.6 million
▼ 26% vs 2024
Profit
Caution€ -13.1 million
▼ 399% vs 2024
Debts
Low€ 35.3 million
▲ 41% vs 2024
NOVADIP BIOSCIENCES from Mont-Saint-Guibert, company number BE0535575602, closed financial year 2025 with a result of € -13.1 million after tax. For that financial year NOVADIP BIOSCIENCES recorded a gross margin of € 1.6 million and equity of € 50 million. Compared with financial year 2024, the result moved from € -2.6 million to € -13.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
What happened at NOVADIP BIOSCIENCES?
What happened at NOVADIP BIOSCIENCES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Drew Trivisonno stepped down as director. NBB
- THERACELL CONSULTING stepped down as director. NBB
- VIVES Partners stepped down as director. NBB
- SPARAXIS stepped down as director. NBB
- Jean-Pierre BIZET stepped down as director. NBB
- AXXIS V&C SRL stepped down as director. NBB
- Patrick VAN BENEDEN stepped down as director. NBB
- Eric PÂQUES stepped down as director. NBB
In short
From € 1.4 million loss in 2021 to € 13.1 million loss in 2025.
Paid € 8 in corporate taxes since 2021.
On average € 41,500 of value added per employee in 2025.
A new publication or filing at NOVADIP BIOSCIENCES? We notify you, reason included.
Follow NOVADIP BIOSCIENCESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Da Liu
Director
Drew Trivisonno
Director
since 2024 · until 2027
Managing director · represented by Denis DUFRANE
since 2021 · until 2027
Director · represented by Philippe DURIEUX
since 2021 · until 2027
Director · represented by Christine Franssen
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2021 · until 2027
Jean-Pierre BIZET
Director
since 2021 · until 2027
since 2021 · until 2027
Patrick VAN BENEDEN
Director
since 2023 · until 2027
Eric PÂQUES
Director
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Rue Granbonpré 11
1435 Mont-Saint-Guibert
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
DE SMET AGRO
€ 8.7 million revenue · 2025
DE SMET S.A. - ENGINEERS & CONTRACTORS same network
€ 31.8 million revenue · 2025
CEDRIC CLAERHOUDT
€ 937,969 gross margin · 2024
Tools4Patient same network
€ -431,027 gross margin · 2025
The Akkermansia Company same network
€ -1.5 million gross margin · 2024
+15 more
Details
- Company number
- 0535.575.602
- VAT number
- BE 0535.575.602
- Registered office
- Rue Granbonpré 11, 1435 Mont-Saint-Guibert
- Names & denominations
- NOVADIP BIOSCIENCES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2013
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied